Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 5, 1996, Pages 1177-1187

  Gaber, Mohamed H ^a,e   Wu, Ning Z ^b   Hong, Keelung ^a   Huang, Shi Kun ^c   Dewhirst, Mark W ^b,d   Papahadjopoulos, Demetrios ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY   (United States)

^c ALZA CORPORATION   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

Carcinoma; Doxorubicin; Extravasation; Hyperthermia; Thermosensitive liposomes; Window chamber

Indexed keywords

CALCEIN; DOXORUBICIN; LIPOSOME; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CALCULATION; DRUG RELEASE; EXTRAVASCULAR SPACE; HEAT SENSITIVITY; LIPID COMPOSITION; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG CARRIERS; FEMALE; HEAT; LIPOSOMES; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344;

EID: 0030444874     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00389-6     Document Type: Article

References (55)

1. 1. Ahmed, I.; Allen, T. M. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped Doxorubicin to lung cancer cells in vitro. Cancer Res 52:4817-1820; 1992.
2. 2. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau Young, A. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biocnim. Biophys. Acta 1066:29-36; 1991.
3. 3. Allen, T. M.; Mehre, T.; Hansen, C.; Chim, Y. C. Stealth liposomes: An improved sustained release system for 1-b-D-Arabinofuranosylcytosine. Cancer Res 52:2431-2439; 1991.
4. 4. Arturson, G. Macrovascular permeability to macromolecules in thermal injury. Acta Physiol. Scand. Suppl. 463:111-122; 1979.
5. 5. Bartlett, G. R. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466-468; 1959.
6. 2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res 50: 1803-1809; 1990.
7. 7. Dewhirst, M. W.; Gross, J. F.; Sim, D. A. Effects of heating rate on normal and tumor microcirculatory function. In: Diller, K. R.; Roemer, R. B., eds. Heat and mass transfer in the microcirculation of thermally significant vessels. American Society of Mechanical Engineers. HTD 61:75-80; 1986.
8. 8. Dewhirst, M. W.; Tso, C. Y.; Oliver, R.; Gutstafson, C. W.; Secomb, T. W.; Gross, J. F. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int. J. Radiat. Oncol. Biol. Phys. 17:91-99; 1989.
9. 9. Embree, L.; Gelmon, K. A.; Lohr, A.; Mayer, L. D.; Coldman, A. J.; Cullis, P. R.; Palaitis, W.; Pilkiewicz, F.; Hudon, N. J.; Heggie, J. R.; Goldie, J. H. Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in nonsmall cell lung cancer patients. J. Pharm. Sci. 82:627-634; 1993.
10. 10. Gaber, M. H.; Hong, K.; Huang, S. K.; Papahadjopoulos, D. Thermosensitive sterically stabilized liposomes: Formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharmacol. Res. 12:1407-1416; 1995.
11. 11. Gabizon, A. A. Selective localization and improved therapeutic index on Anthracyclines encapsulating in long-circulating liposomes. Cancer Res 52:891-896; 1992.
12. 12. Gerlowski, L. E.; Jain, R. K. Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. Int. J. Microcirc. Clin. Exp. 4:363-372; 1985.
13. 13. Gregoriadis, G.; Hunt, R. Fate of a liposome-associated agent injected into normal and tumor-bearing rodents. Attempts to improve localization in tumor tissues. Life Sci. 21:357-369; 1977.
14. 14. Gregoriadis, G.; Neerunjum, D. E. Homing of liposomes to target cells. Biochem. Biophys. Res. Commun. 65:537-544; 1975.
15. 15. Gross, J. F.; Roemer, R.; Dewhirst, M.; Meyer, M. A uniform thermal field in a hyperthermia chamber for microvascular studies. Int. J. Heat Mass Transfer 25:1313-1320; 1982.
16. 16. Hahn, G. M.; Braun, J.; Her-Kedcar, I. Thermochemotherapy synergism between hyperthermia (42°-43°) and adriamycin (or bleomycin) in mammalian cell inactivation. Proc. Natl. Acad. Sci. USA 72:937-940; 1975.
17. 17. Hahn, G. M.; Strande, D. P. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J. Natl. Cancer Inst. 57:1063-1067; 1976.
18. 18. Heath, T. D.; Fraley, R.; Papahadjopoulos, D. Antibody targeting of liposomes: Cell specificity obtained by conjugation of F(ab)2 to vesicle surface. Science 210:539-541; 1980.
19. 19. Huang, S. K.; Lee, K. D.; Hong, K.; Friend, D. S.; Papahadjopoulos, D. Microscopic localization of sterically stabilized liposomes in colon carcinoma bearing mice. Cancer Res. 52:5135-5143; 1992.
20. 20. Huang, S. K.; Stauffer, P. R.; Hong, K.; Guo, J. W. H.; Philips, T. L.; Huang, A.; Papahadjopoulos, D. Liposome and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of Doxorubicin in sterically stabilized liposomes. Cancer Res 54:2186-2191; 1994.
21. 21. Iga, K.; Hamaguchi, N.; Igari, Y.; Ogawa, Y.; Toguchi, H.; Shimamoto, T. Increased tumor cisplatin levels in heated tumors in mice after administration of thermosensitive large unilamellar vesicles encapsulating cisplatin. J. Pharm. Sci. 80:522-525; 1991.
22. 22. Jain, R. K. Physiological barriers to delivery of monoclonal antibodies and other Macromolecules in tumors. Cancer Res. 50:814s-819s; 1990.
23. 23. Jain, R. K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6:559-594; 1987.
24. 24. Lasic, D. D., ed. Liposomes from physics to applications Amsterdam: Elsevier; 1993:265-318
25. 25. Lasic, D. D.; Frederik, P. M.; Stuart, Y.; Barenholz, Y.; Mcintosh, T. J. Gelation of liposome interior: A novel method for drug encapsulation. FEBS J 312:255-258; 1992.
26. 26. Lasic, D. D.; Martin, F. J.; Gabizon, A.; Huang, S. K.; Papahadjopoulos, D. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070:187-192; 1991.
27. 27. Leserman, L. D.; Weinstein, J. N.; Blumenthal, R.; Sharrow, S. O.; Terry, W. D. Binding of antigen-bearing fluorescent liposomes to the murine myeloma tumor MOPC 315. J. Immunol. 122:585-591; 1979.
28. 28. Marmor, J. B. Interaction of hyperthermia and chemotherapy in animals. Cancer Res 39:2269-2276; 1979.
29. 29. Maruyama, K.; Unezaki, S.; Takahashi, N.; Iwatsuru, M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta 1149:209-216; 1993.
30. 30. Merlin, J. L. Encapsulation of doxorubicin in thermosensitive small unilamellar vesicle liposomes. Eur. J. Cancer 27:1026-1030; 1991.
31. 31. Needham, D.; Histova, K.; Mcintosh, T. J.; Dewhirst, M.; Wu, N.; Lasic, D. D. Polymer-grafted liposomes: Physical basis for the "stealth" property. J. Liposome Res 2:411-430; 1992.
32. 32. Needham, D.; Mcintosh, T. J.; Lasic, D. D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta 1108:40-48; 1992.
33. 33. Newman, R. A.; Dograntzis, D.; Benvenuto, M.; Trevino, L. C.; Stephens, J.; Wondergem, R.;; Strebel, R.; Baba, J. M.; Bull, J. M. Effect of whole-body hyperthermia on pharmacokinetics and tissue distribution of doxorubicin. Int. J. Hyperthermia 8:79-85; 1992.
34. 34. Nicholis, G.; Clark, B. J.; Brown, J. E. Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatography. J. Pharmaceut. Biomed. Anal. 10:949-957; 1992.
35. 35. Olson, F. C.; Hunt, C. A.; Szoka, F.; Vail, W. J.; Papahadjopoulos, D. Preparation of liposomes of denned size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 557:9-23; 1979.
36. 36. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, K.; Matthay, K.; Huang, S. K.; Lee, K. D.; Woodle, M. C.; Lasic, D. D.; Redemann, C.; Martin, F. J. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88:11460-11464; 1991.
37. 37. Papahadjopoulos, D.; Jacobson, K.; Nir, S.; Isac, T. Phase transitions in phospholipid vesicles: Fluorescence polarization and permeability properties concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta 311:330-348; 1973.
38. 38. Peeters, P. A. M.; Storm, G.; Crommelin, D. J. A. Immunoliposoms in vivo: State of the art. Adv. Drug Deliv. Rev. 1:249-266; 1987.
39. 39. Senior, J. H. Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Crit. Rev. Ther. Drug Carrier Systems 3:123-193; 1987.
40. 40. Seymour, L. W.; Ulbrich, K.; Strohalm, J.; Kopecek, J.; Duncan, R. The pharmacokinetics of polymer-bound adriamycin. Biochem. Pharmacol. 39:1125-1131; 1990.
41. 41. Song, C. W. Effect of hyperthermia on vascular functions of normal tissues and experimental tumors: Brief communication. J. Natl. Cancer Inst. 60:711-713; 1978.
42. 42. Song, C. W.; Kang, M. S.; Rhees, J. G.; Levitt, S. H. Effect of hyperthermia on vascular function in normal and neoplastic tissues. Ann. NY Acad. Sci. 335:35-47; 1980.
43. 43. Szoka, F. C.; Olson, F.; Heath, T.; Vail, W.; Mayhew, E.; Papahadjopoulos, D. Preparation of unilamellar liposome of intermediate size (0.1-0.2 mm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim. Biophys. Acta 601:559-571; 1980.
44. 44. Szoka, F. C.; Papahadjopoulos, D. Comparative properties and methods of preparation of lipid vesicles. Annu. Rev. Biophys. Bioeng. 9:467-508; 1980.
45. 45. Torchilin, V. P. Liposomes as targetable drug carriers. CRC Crit. Rev. Ther. Drug Carrier Systems 2:65-115; 1985.
46. 46. Weinstein, J. N.; Magin, R. L.; Cysyl, R. L.; Zaharko, D. S. Treatment of solid L1210 Murine tumors with local hyperthermia and temperature-sensitive liposomes containing Methotrexate. Cancer Res 40:1388-1395; 1980.
47. 47. Woodle, M. C.; Lasic, D. D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1113:171-199; 1992.
48. 48. Wright, S.; Huang, L. Antibody-directed liposomes as drug-delivery vehicles. Adv. Drug Deliv. Rev. 3:343-389; 1989.
49. 49. Wu, N. Z.; Da, D.; Rudoll, T. L.; Needham, D.; Whorton, A. R.; Dewhirst, M. W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 53:3765-3770; 1993.
50. 50. Wu, N. Z.; Klitzman, B.; Rosner, G.; Needham, D.; Dewhirst, M. W. Measurement of material extravasation in microvascular networks using fluorescence video. microscopy. Microvasc Res 46:231-253; 1993.
51. 51. Wu, N. Z.; Braun, R. D.; Gaber, M. H.; Lin, G. M.; Ong, E. T.; Shan, S.; Papahadjopoulos, D.; Dewhirst, M. W. Simultaneous measurement of liposome extravasation and content release in tumors. Microcirculation (submitted).
52. 52. Yatvin, M. B.; Muhlesiepen, H.; Porschen, W.; Weinstein, J. N.; Feinendegen, L. E. Selective delivery of liposome-associated cis-Dichlorodiammineplatinum (II) by heat and its influence on tumor drug uptake and growth. Cancer Res 41:1602-1607; 1981.
53. 53. Yatvin, M. B.; Weinstein, J. N.; Dennis, W. H.; Blumenhal, R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202:1290-1293; 1978.
54. 54. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Microvascular permeability and interstitial penetration of sterically stabilized liposomes in a human tumor xenograft. Cancer Res 54:3352-3356; 1994.
55. 55. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 55:3752-3756; 1995.